Inventor
LIN KUO-SHYAN
CA10 patents
⚠️ This page may combine multiple inventors who share the name “LIN KUO-SHYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROVINCIAL HEALTH SERVICES AUTHORITY
6 patentsUS11395857B2Jul 26, 2022
Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy
PROVINCIAL HEALTH SERVICES AUTHORITY3 citations69
US11992537B2May 28, 2024
Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy
PROVINCIAL HEALTH SERVICES AUTHORITY0 citations59
US11504441B2Nov 22, 2022
Radiolabeled compounds targeting the prostate-specific membrane antigen
PROVINCIAL HEALTH SERVICES AUTHORITY1 citations58
US12246076B2Mar 11, 2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders
PROVINCIAL HEALTH SERVICES AUTHORITY0 citations57
US12427209B2Sep 30, 2025
Dual mode 18F-labelled theranostic compounds and uses thereof
PROVINCIAL HEALTH SERVICES AUTHORITY1 citations56
US12472272B2Nov 18, 2025
Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancer
PROVINCIAL HEALTH SERVICES AUTHORITY0 citations46
BRITISH COLUMBIA CANCER AGENCY BRANCH
3 patentsUS10150804B2Dec 11, 2018
Compositions and methods for imaging cancer
BRITISH COLUMBIA CANCER AGENCY BRANCH6 citations68
US10882871B2Jan 5, 2021
18/19F-labelled compounds which target the prostate specific membrane antigen
BRITISH COLUMBIA CANCER AGENCY BRANCH3 citations66
US10039846B2Aug 7, 2018
Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders
BRITISH COLUMBIA CANCER AGENCY BRANCH1 citations43